394 related articles for article (PubMed ID: 27261903)
21. The epidemiology of non-alcoholic fatty liver disease.
Bellentani S
Liver Int; 2017 Jan; 37 Suppl 1():81-84. PubMed ID: 28052624
[TBL] [Abstract][Full Text] [Related]
22. A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management.
Vorobioff JD; Contreras F; Tanno F; Hernández L; Bessone F; Colombato L; Adi J; Fassio E; Felgueres M; Fernández G; Gaite L; Gibelli D; Darrichon HG; Lafage M; Lombardo D; López S; Mateo A; Mendizábal M; Pecoraro J; Ruf A; Ruiz P; Severini J; Stieben T; Sixto M; Zárate F; Barraza SB; Sierra ID; Pacheco VR; Roblero JP; Rojas JO; González PR; Rodríguez DSM; Sierralta A; Manchego AU; Valdes E; Yaquich P; Wolff R; Valdivia FB; Gallegos RC; Galloso R; Marcelo JS; Montes P; Tenorio L; Veramendi I; Alava E; Armijos X; Benalcazar G; Carrera E; Pazmiño GF; Díaz EM; Garassini M; Marrero RP; Infante M; Suárez DP; Gutiérrez JC; Reyes CMV; Serrano YM; Hernández RH; Martínez OM; González TP; Andara MT; Hernández MS; Gerona S; García I; Tijera F; López EP; Torres K; Garzón M
Ann Hepatol; 2020; 19(4):396-403. PubMed ID: 32418749
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma and non-alcoholic fatty liver disease.
Golabi P; Rhea L; Henry L; Younossi ZM
Hepatol Int; 2019 Nov; 13(6):688-694. PubMed ID: 31701393
[TBL] [Abstract][Full Text] [Related]
24. [Histological findings in the liver in patients with chronic hepatitis C].
Takase K; Shiraki K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):434-8. PubMed ID: 15359838
[No Abstract] [Full Text] [Related]
25. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
26. Letter to the Editor: Consider More Factors When Studying Risk of Cirrhosis and Hepatocellular Cancer in Patients With Nonalcoholic Fatty Liver Disease.
Yang NB; Li GX; Chu JG; Wang YJ
Hepatology; 2020 Jun; 71(6):2172-2173. PubMed ID: 31849080
[No Abstract] [Full Text] [Related]
27. [Epidemiology and natural history of cirrhosis].
Naveau S; Perlemuter G; Balian A
Rev Prat; 2005 Sep; 55(14):1527-32. PubMed ID: 16255293
[TBL] [Abstract][Full Text] [Related]
28. Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey.
Cotrim HP; Oliveira CP; Coelho HS; Alvares-da-Silva MR; Nabuco L; Parise ER; Ivantes C; Martinelli AL; Galizzi-Filho J; Carrilho FJ
Clinics (Sao Paulo); 2016 May; 71(5):281-4. PubMed ID: 27276398
[TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.
Pais R; Lebray P; Rousseau G; Charlotte F; Esselma G; Savier E; Thabut D; Rudler M; Eyraud D; Vezinet C; Siksik JM; Vaillant JC; Hannoun L; Poynard T; Ratziu V
Clin Gastroenterol Hepatol; 2015 May; 13(5):992-9.e2. PubMed ID: 25459558
[TBL] [Abstract][Full Text] [Related]
31. Liver disease in alcohol and hepatitis C.
Jamal MM; Morgan TR
Best Pract Res Clin Gastroenterol; 2003 Aug; 17(4):649-62. PubMed ID: 12828960
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK; Sanyal AJ
Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
[TBL] [Abstract][Full Text] [Related]
33. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
34. The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.
Lindenmeyer CC; McCullough AJ
Clin Liver Dis; 2018 Feb; 22(1):11-21. PubMed ID: 29128051
[TBL] [Abstract][Full Text] [Related]
35. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
[TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
[TBL] [Abstract][Full Text] [Related]
37. [Impact of antiviral therapy on the natural history of hepatitis C virus].
Fernández Rodriguez CM; Gutierrez Garcia ML
Gastroenterol Hepatol; 2014 Dec; 37(10):583-92. PubMed ID: 25066318
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C: frequency and risk factors associated with sero-positivity among adults in Larkana City.
Shaikh FH; Ali Abro H; Ali Chhutto M; Abbasi PA; Shaikh AW; Ali Buriro S
J Ayub Med Coll Abbottabad; 2009; 21(2):107-9. PubMed ID: 20524483
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
[TBL] [Abstract][Full Text] [Related]
40. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.
Tanaka J; Kumada H; Ikeda K; Chayama K; Mizui M; Hino K; Katayama K; Kumagai J; Komiya Y; Miyakawa Y; Yoshizawa H
J Med Virol; 2003 Jul; 70(3):378-86. PubMed ID: 12767000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
